환자 종양으로 먼저 약효 시험한다”… KAIST, 악성 뇌종양 맞춤치료 길 열었다 – 특허뉴스
Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have developed a precision medicine platform designed to predict the efficacy of drug treatments for glioblastoma before administration, according to institutional reports. This development addresses one of the most significant challenges in neuro-oncology: the highly heterogeneous nature of glioblastoma, a malignant brain tumor known … Read more